A medication that is currently used for chronic kidney disease in patients with type 2 diabetes has been found to reduce the risk of worsening heart failure and cardiovascular death in certain people ...
Adam Ennamli is Chief Risk Officer at General Bank of Canada & former VP O&T at Thomson Reuters. Global Board advisor on strategy and risk. Many organizations invest heavily in risk management ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results